-Reuters
Small SPAC Biotech Apexigen To Be Acquired Pyxis Oncology For $16M
Pyxis Oncology Inc (NASDAQ:PYXS) agreed to acquire Apexigen Inc (NASDAQ:APGN) in an all-stock transaction for an implied value of $0.64…
Related Posts
Brown & Brown Announces The Asset Acquisition Of Vistanational Insurance Group; No Terms Disclosed
DAYTONA BEACH, Fla., Sept. 12, 2022 (GLOBE NEWSWIRE) -- J. Scott Penny, chief acquisitions officer of Brown & Brown, Inc. (NYSE:BRO), and Kahlil Hogan, Thomas Mathew, Richard Mathews, William Novak, David N.
Elon Musk Serves 2nd Termination Letter To Twitter On Undisclosed Bases: What You Need To Know
Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk sent a second termination letter to Twitter, Inc.
